Top Stories
The ECG2Stroke model was trained and validated on data from more than 200,000 patients.
The diagnostic is the first AI-powered digital pathology prognostic test to receive the designation for bladder cancer.
Up to 71% of clinically significant lung nodules lack appropriate follow-up, while high-risk pulmonary embolism patients can face treatment delays.
The pharma will use Tempus' Lens platform to pressure-test trial assumptions and stratify patient groups across five initial programmes spanning solid tumours and Alzheimer's disease.
Partnership targets speedier development of vaccines and therapies, as well as disease forecasting and health-system planning in lower-income countries.
Conference News
An AI technology is effective at planning the delivery of life-saving radiotherapy for cervical cancer and prostate cancer, according to results from a large international trial led by researchers at ...
SAN FRANCISCO, CA, UNITED STATES, May 16, 2026 /EINPresswire.com/ -- Mentavi Health, a telehealth provider of evidence-based digital mental health care for adults (18+), will present data from a clini...
STOCKHOLM, May 15, 2026 /PRNewswire/ -- United Imaging, a global innovator in AI-powered advanced medical imaging technologies and intelligent healthcare solutions, unveiled its comprehensive portfoli...
Ahead of ASCO 2026, Phesi president warns that “flaws are being scaled, not solved” as AI tools rely on historical protocol templates without patient data or contextBoston, USA, 13 May 2026. Phesi, a ...
Data highlight advancements across ElevateBio's targeted gene insertion platform, powered by retrotransposon and machine learning-optimized recombinase approaches, and its new epigenetic editing platf...
